Models and approaches to comprehend and address glial inflammation following spinal cord injury
Authors:
Open Access
- 22 July 2023
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 28 (10) , 103722
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland
- European Regional Development Fund (13/RC/2073_P2)
- SFI
This publication has 116 references indexed in Scilit:
- A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injuryJournal of Neuroinflammation, 2013
- SyM-BBB: a microfluidic blood brain barrier modelLab on a Chip, 2012
- Intravenous administration of granulocyte colony-stimulating factor for treating neuropathic pain associated with compression myelopathy: a phase I and IIa clinical trialEuropean Spine Journal, 2012
- A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s diseaseJournal of Neuroinflammation, 2012
- Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, part 1: a phase I and IIa clinical trialEuropean Spine Journal, 2011
- Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells ‘feel’ outside and in?Journal of Cell Science, 2010
- Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injuryBrain, 2009
- A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosisJournal of Tissue Engineering and Regenerative Medicine, 2009
- GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injuryJournal of the Neurological Sciences, 2009
- Two Faces of Chondroitin Sulfate Proteoglycan in Spinal Cord Repair: A Role in Microglia/Macrophage ActivationPLOS Medicine, 2008